Results
1 -
10 of
14Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice, Breast Cancer Research and Treatment Luteinizing Hormone-Releasing Hormone and Its Agonistic, Antagonistic, and Targeted Cytotoxic Analogs in Prostate Cancer, Drug Management of Prostate Cancer Twenty-five Years of Endocrine Oncology with Analogs of Hypothalamic Peptides: An Overview, Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance Two-Photon Processes: Dynamics and Applications, Multiphoton and Light Driven Multielectron Processes in Organics: New Phenomena, Materials and Applications Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH), Archives of Gynecology and Obstetrics A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicinu2014integration of in vitro results, Phase I and Phase II data and model application for drugu2013drug interaction potential analysis, Cancer Chemotherapy and Pharmacology Endokrine Therapie der Zukunft, Gyn??kologische Endokrinologie Experimentelle Therapie gyn??kologischer Tumoren mit Peptidanaloga, Gyn??kologische Endokrinologie Treatment for triple-negative breast cancer, The Chinese-German Journal of Clinical Oncology Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system, Breast Cancer Research and Treatment